# AXIOS CHINA (E7148)

> **NCT03808272** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 31 (actual)

## Conditions studied

- Pancreatic Pseudocyst and Walled-off Necrosis

## Interventions

- **DEVICE:** HOT AXIOS Stent and Electrocautery- Enhanced Delivery System

## Key facts

- **NCT ID:** NCT03808272
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-17
- **Primary completion:** 2020-12-24
- **Final completion:** 2021-10-30
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03808272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03808272, "AXIOS CHINA (E7148)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03808272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*